March 17, 2021
NNHPD’s newly appointed Director General, Natalie Page, opened the meeting with her team and officials from the Inspectorate (ROEB) providing the updates on the following key items:
• COVID backlog and the measures in place to clear the back-log and resume normal performance standards now that the influx of pandemic-related registrations such as hand-sanitizers has subsided
• Forward Regulatory Plan and assurances of Health Canada’s post Covid-19 commitment to the Self-Care Framework as a priority
• NHP Inspections and work towards establishing an NHP GMP Inspection Program Pilot that moves away from from the prescriptive drug inspection model, in keeping with the principles of Self-Care
• Cannabis Science Advisory Committee which will provide independent scientific and clinical advice to support the Department’s consideration of appropriate safety, efficacy, and quality standards for health products containing cannabis
Linda Beach is the founder, sole owner, and Director of Canadian Natural Health Product Registry (CNHPR), operating under Medical Botany Research. Based on Canada’s west coast, Linda has been providing regulatory consulting and compliance expertise to Canadian and international companies since 2004, when Canada’s Natural Health Products Regulations first came into effect.
A Certified Herbalist with a degree in Botany and Medical Research, Linda also holds certifications in several natural and complementary healing modalities. This combination of scientific training and hands-on herbal expertise gives her a unique perspective on the products she helps bring to market — from vitamins and herbal remedies to nutraceuticals, cosmeceuticals, and sports supplements.
Over her two decades working directly with Health Canada, Linda has built strong working relationships with regulators that have translated into consistent success in securing Natural Product Numbers (NPNs) for her clients. Her advocacy work has had industry-wide impact — including playing a key role in Health Canada’s decision to reinstate hempseed oil to its approved ingredient database after it had been removed, restoring a path to market for products containing the ingredient.
Through CNHPR, Linda guides clients through every stage of the licensing process: developing a tailored regulatory strategy, compiling required documentation, and managing submissions from signing through to Health Canada approval.